PAVMED INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$1.95
-1.02%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-27.8%
3 months
-64.5%
6 months
-77.1%
1 year
-84.6%
Year to date
-70.6%
52-week range
$1.95 – $12.87
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$15.6M
P/E
-0.8
P/B
0.4
P/S
139.3
Revenue
$112K
Net income
-$12.09M
Diluted EPS
-16.32
Gross margin
-220.50%
Net margin
-18417.00%
Return on equity
-58.50%
Total debt
$17.07M
Cash
$3.78M
Free cash flow
-$7.78M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $33K | -$5.38M | -269.70% | -16603.00% | -$2.68M |
| Mar 31, 2026 | $22K | -$60K | -340.90% | -31763.60% | -$2.64M |
| Dec 31, 2025 | $52K | -$1.26M | -63.50% | -3523.10% | -$1.57M |
| Sep 30, 2025 | $5K | -$5.38M | -1000.00% | -126560.00% | -$899K |
| Jun 30, 2025 | $6K | -$11.92M | -583.30% | -221800.00% | -$1.19M |
| Mar 31, 2025 | $8K | $18.97M | -350.00% | 221187.50% | -$1.59M |
| Dec 31, 2024 | $10K | $1.43M | -380.00% | 13460.00% | $90K |
| Sep 30, 2024 | $996K | $64.4M | -38.70% | 6457.40% | -$8.89M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent PAVM news
All market newsNo ticker-linked stories are in the current archive.